Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- DHR
- Price
- 196.39
- Stock movement up
- +1.95 (1.00%)
- Company name
- Danaher Corporation
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 140.63B
- Ent value
- 167.31B
- Price/Sales
- 7.02
- Price/Book
- 2.74
- Div yield
- 0.65%
- Div growth
- 11.75%
- Growth years
- 7
- FCF payout
- 15.43%
- Trailing P/E
- 36.13
- Forward P/E
- 22.85
- PEG
- 2.78
- EPS growth
- 14.04%
- 1 year return
- -22.72%
- 3 year return
- -2.96%
- 5 year return
- 5.25%
- 10 year return
- 13.14%
Last updated: 2025-08-27
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 1.28 |
| Dividend yield | 0.65% |
| Payout frequency | Quarterly |
| Maximum yield | 0.73% |
| Average yield | 0.40% |
| Minimum yield | 0.25% |
| Discount to avg yield | 38.11% |
| Upside potential | 61.58% |
| Yield as % of max yield | 88.93% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 0.65% |
| Current yield distribution | 2.78% |
| Yield at 100% (Min) | 0.25% |
| Yield at 90% | 0.30% |
| Yield at 80% | 0.34% |
| Yield at 50% (Median) | 0.39% |
| Yield at 20% | 0.45% |
| Yield at 10% | 0.50% |
| Yield at 0% (Max) | 0.73% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | 7 years |
| CCC status | Dividend Challenger |
| Dividend per share | 1.28 |
| Payout frequency | Quarterly |
| Ex-div date | 27 Jun 2025 |
| EPS (TTM) | 5.34 |
| EPS (1y forward) | 8.60 |
| EPS growth (5y) | 14.04% |
| EPS growth (5y forward) | 13.02% |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| DHR | S&P500 | |
| DGR MR | 18.52% | -13.74% |
| DGR TTM | 12.38% | 6.60% |
| DGR 3 years | 15.70% | 5.24% |
| DGR 5 years | 11.75% | 5.40% |
| DGR 10 years | 30.89% | 7.07% |
| DGR 15 years | 23.76% | 6.12% |
| Time since last change announced | 192 days |
| EPS growth (5y) | 14.04% |
| EPS growth (5y forward) | 13.02% |
Payout ratio
Loading...
Please create a free account or log in to access this chart
Payout ratio data
| EPS coverage | FCF coverage | |
| TTM | 19.86% | 15.43% |
| Average | - | - |
| Forward | 14.89% | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 36.13 |
| Price to OCF | 22.36 |
| Price to FCF | 28.07 |
| Price to EBITDA | 21.54 |
| EV to EBITDA | 25.62 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 7.02 |
| Price to Book | 2.74 |
| EV to Sales | 8.35 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 716.05M |
| EPS (TTM) | 5.34 |
| FCF per share (TTM) | 6.87 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 20.03B |
| Gross profit (TTM) | 11.94B |
| Operating income (TTM) | 3.98B |
| Net income (TTM) | 3.89B |
| EPS (TTM) | 5.34 |
| EPS (1y forward) | 8.60 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 59.61% |
| Operating margin (TTM) | 19.87% |
| Profit margin (TTM) | 19.43% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.63B |
| Net receivables | 3.51B |
| Total current assets | 10.06B |
| Goodwill | 42.17B |
| Intangible assets | 19.85B |
| Property, plant and equipment | 9.04B |
| Total assets | 80.61B |
| Accounts payable | 1.60B |
| Short/Current long term debt | 17.52B |
| Total current liabilities | 7.34B |
| Total liabilities | 29.31B |
| Shareholder's equity | 51.30B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 6.29B |
| Capital expenditures (TTM) | 1.28B |
| Free cash flow (TTM) | 5.01B |
| Dividends paid (TTM) | 773.00M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 7.59% |
| Return on Assets | 4.83% |
| Return on Invested Capital | 5.65% |
| Cash Return on Invested Capital | 7.28% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 196.53 |
| Daily high | 196.60 |
| Daily low | 194.22 |
| Daily Volume | 6.55M |
| All-time high | 294.71 |
| 1y analyst estimate | 245.95 |
| Beta | 0.76 |
| EPS (TTM) | 5.34 |
| Dividend per share | 1.28 |
| Ex-div date | 27 Jun 2025 |
| Next earnings date | 21 Oct 2025 |
Downside potential
Loading...
Downside potential data
| DHR | S&P500 | |
| Current price drop from All-time high | -33.36% | -3.04% |
| Highest price drop | -45.85% | -56.47% |
| Date of highest drop | 8 Mar 2000 | 9 Mar 2009 |
| Avg drop from high | -9.36% | -11.04% |
| Avg time to new high | 13 days | 12 days |
| Max time to new high | 952 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
140.63B
Marketcap category
Large-cap
Description
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a partnership with AstraZeneca PLC to develop and commercialize diagnostic tools and tests. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and
Employees
61000
Website
Investor relations
SEC filings
CEO
H. Lawrence Culp
Country
USA
City
Washington
Stock type
Common stock
CCC status
Dividend Challenger
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page